References
- Azziz R, Woods KS, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89:2745–2749.
- Sheehan MT. Polycystic ovarian syndrome: diagnosis and management. Clin Med Res. 2004;2:13–27.
- Norman RJ, Dewailly D, Legro RS, et al. Polycystic ovary syndrome. Lancet. 2007;370:685–697.
- Goodarzi MO, Dumesic DA, Chazenbalk G, et al. Polycystic ovary syndrome: etiology, pathogenesis and diagnosis. Nat Rev Endocrinol. 2011;7:219–231.
- Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19–25.
- Dunaif A. Polycystic ovary syndrome in 2011: genes, aging and sleep apnea in polycystic ovary syndrome. Nat Rev Endocrinol. 2011;8:72–74.
- Diamanti-Kandarakis E, Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33:981–1030.
- Traub ML. Assessing and treating insulin resistance in women with polycystic ovarian syndrome. World J Diabetes. 2011;2:33–40.
- Snyder ML, Shields KJ, Korytkowski MT, et al. Complement protein C3 and coronary artery calcium in middle-aged women with polycystic ovary syndrome and controls. Gynecol Endocrinol. 2014;30:511–515.
- Gunning MN, Fauser BCJM. Are women with polycystic ovary syndrome at increased cardiovascular disease risk later in life?. Climacteric. 2017;20:222–227.
- Stewart DR, Dombroski BA, Urbanek M, et al. Fine mapping of genetic susceptibility to polycystic ovary syndrome on chromosome 19p13.2 and tests for regulatory activity. J Clin Endocrinol Metab. 2006; 91:4112–4117.
- Chen ZJ, Shi Y. Polycystic ovary syndrome. Front Med China. 2010;4:280–284.
- Li S, Zhao L, Wan XH. A missense variant rs4645843 in TNF-α gene is a risk factor of polycystic ovary syndrome in the Uygur population. Tohoku J Exp Med. 2017;243:95–100.
- Geva E, Jaffe RB, Edward WE. Role of vascular endothelial growth factor in ovarian physiology and pathology. Fertil Steril. 2000;74:429–438.
- Agrawal R, Sladkevicius P, Engmann L, et al. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries. Hum Reprod. 1998; 13:651–655.
- Kamat BR, Brown LF, Manseau EJ, et al. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol. 1995;146:157–165.
- Vincenti V, Cassano C, Rocchi M, et al. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation. 1996;93:1493–1495.
- Zhao ZZ, Nyholt DR, Thomas S, et al. Polymorphisms in the vascular endothelial growth factor gene and the risk of familial endometriosis. Mol Hum Reprod. 2008; 14:531–538.
- Berse B, Brown LF, Van De Water L, et al. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. MBoC. 1992; 3:211–213.
- Stevens A, Soden J, Brenchley PE, et al. Haplotype analysis of the polymorphic vascular endothelial growth factor gene promoter. Cancer Res. 2003;63:812–816.
- Watson CJ, Webb NJ, Bottomley MJ, et al. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine. 2000; 12:1232–1236.
- Banyasz I, Szabo S, Bokodi G, et al. Genetic polymorphisms of vascular endothelial growth factor in severe preeclampsia. Mol Hum Reprod. 2006;12:233–236.
- Nagy B, Savli H, Molvarec A, et al. Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses. Clin Chim Acta. 2008; 389:126–131.
- Kim SH, Choi YM, Choung SH, et al. Vascular endothelial growth factor gene +405C/G polymorphism is associated with susceptibility to advanced stage endometriosis. Hum Reprod. 2005;20:2904–2908.
- Altinkaya SO, Ugur M, Ceylaner G, et al. Vascular endothelial growth factor +405 C/G polymorphism is highly associated with an increased risk of endometriosis in Turkish women. Arch Gynecol Obstet. 2011;283:267–272.
- Bhanoori M, Arvind Babu K, Pavankumar Reddy NG, et al. The vascular endothelial growth factor (VEGF) 1405G > C 50-untranslated region polymorphism and increased risk of endometriosis in South Indian women: a case control study. Hum Reprod. 2005;20:1844–1849.
- Vural P, Kusku-Kiraz Z, Dogru-Abbasoglu S, et al. Vascular endothelial growth factor -2578 A/C, -460 T/C and +405 G/C polymorphisms in polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2009;147:57–60.
- Guruvaiah P, Govatati S, Venkat Reddy T, et al. The VEGF +405 G > C 5' untranslated region polymorphism and risk of PCOS: a study in the South Indian Women. J Assist Reprod Genet. 2014;31:1383–1389.
- The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41–47.
- Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215–1217.